Comparing the Cardiotoxic Effects of Continuous Infusion and Bolus Injection of Doxorubicin in Children with Acute Lymphoblastic Leukemia (ALL)
نویسندگان
1 Clinical pharmacy department, Faculty of pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran - Clinical pharmacy department, Faculty of pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2 Hematology and Oncology Research Center, Shahid Sadoughi hospital, School of medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran - Hematology and Oncology Research Center, Shahid Sadoughi hospital, School of medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
3 Hematology and Oncology Research Center, Shahid Sadoughi hospital, School of medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran - Hematology and Oncology Research Center, Shahid Sadoughi hospital, School of medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4 Department of Pathology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran - Department of Pathology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
5 Hematology and Oncology Research Center, Shahid Sadoughi hospital, School of medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran - Hematology and Oncology Research Center, Shahid Sadoughi hospital, School of medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
doi
10.18502/ijpho.v15i3.18916چکیده
Background: Cardiotoxicity is a common complication associated with chemotherapy drugs. However, limited evidence exists regarding the cardiotoxic effects of continuous infusion versus bolus injection of doxorubicin. Since no comprehensive study has been conducted on this issue in our country—particularly in Yazd city—this study aimed to compare the cardiotoxicity of bolus injection ...
